These observations led to the concept that an impairment in the IDO pathway could be involved in the development of autoimmune disease including MS, and resulted in the idea that modulation of IDO expression and activity could be beneficial in autoimmunity. This evidence concerns the gene IDO1 and autoimmune disease.